Therapeutic Category of Drugs in Japan

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     ATC
 1  Agents affecting nervous system and sensory organs
   11  Agents affecting central nervous system
   12  Agents affecting peripheral nervous system
     121  Local anesthetics
     122  Skeletal muscle relaxants
     123  Autonomic nervous system agents
     124  Antispasmodics
       1241  Diphenylglycolates
       1242  Atropines
         D01201  Tiemonium iodide (JAN/INN)
         D02069  Atropine sulfate (JP16/USP)
         D01451  Scopolamine butylbromide (JP16)
         D01976  N-Methylscopolamine methylsulfate (JAN)
         D02071  Scopolamine hydrobromide hydrate (JP16); Scopolamine hydrobromide (USP)
         D01491  Butropium bromide (JP16/INN)
A03AB17
A03BA01 S01FA01
A03BB01
A03BB03 S01FA03
A04AD01 N05CM05 S01FA02
 
       1243  Papaverines
       1244  Magnesium salts
       1245  Alkaloids
       1249  Others
     125  Diaphoretics, anhidrotics
     129  Miscellaneous
   13  Agents affecting sensory organs
   19  Other agents affecting nervous system and sensory organs
 
 2  Agents affecting individual organs
 
 3  Agents affecting metabolism
 
 4  Agents affecting cellular function
 
 5  Crude drugs and Chinese medicine formulations
 
 6  Agents against pathologic organisms and parasites
 
 7  Agents not mainly for therapeutic purpose
 
 8  Narcotics

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: November 26, 2014
Classification code 87 in the Japan Standard Commodity Classification

» Japanese version